Literature DB >> 14748726

B-cell antigen receptor activates transcription factors NFAT (nuclear factor of activated T-cells) and NF-kappaB (nuclear factor kappaB) via a mechanism that involves diacylglycerol.

P Antony1, J B Petro, G Carlesso, N P Shinners, J Lowe, W N Khan.   

Abstract

Engagement of the B-cell antigen receptor (BCR) induces the activation of various transcription factors, including NFAT (nuclear factor of activated T-cells) and NF-kappaB (nuclear factor kappaB), which participate in long-term biological responses such as proliferation, survival and differentiation of B-lymphocytes. We addressed the biochemical basis of this process using the DT40 chicken B-cell lymphoma. We discovered that Bruton's tyrosine kinase (BTK) and phospholipase C-gamma2 (PLC-gamma2) are required to activate NFAT and NF-kappaB, and to produce the lipid second messenger diacylglycerol in response to BCR cross-linking. Therefore the functional integrity of the BTK/PLC-gamma2/diacylglycerol signalling axis is crucial for BCR-directed activation of both transcription factors NFAT and NF-kappaB.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14748726     DOI: 10.1042/bst0320113

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  11 in total

1.  3BP2 deficiency impairs the response of B cells, but not T cells, to antigen receptor ligation.

Authors:  Miguel A de la Fuente; Lalit Kumar; Bao Lu; Raif S Geha
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

Review 2.  BTK inhibitors in chronic lymphocytic leukemia: a glimpse to the future.

Authors:  M Spaargaren; M F M de Rooij; A P Kater; E Eldering
Journal:  Oncogene       Date:  2014-06-23       Impact factor: 9.867

3.  Bruton's tyrosine kinase promotes persistence of mature anti-insulin B cells.

Authors:  Rachel H Bonami; Allison M Sullivan; James B Case; Hannah E Steinberg; Kristen L Hoek; Wasif N Khan; Peggy L Kendall
Journal:  J Immunol       Date:  2014-01-22       Impact factor: 5.422

4.  PLCgamma2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2.

Authors:  Dailing Mao; Holly Epple; Brian Uthgenannt; Deborah V Novack; Roberta Faccio
Journal:  J Clin Invest       Date:  2006-10-19       Impact factor: 14.808

5.  The mouse B cell-specific mb-1 gene encodes an immunoreceptor tyrosine-based activation motif (ITAM) protein that may be evolutionarily conserved in diverse species by purifying selection.

Authors:  Richard Sims; Virginia Oberholzer Vandergon; Cindy S Malone
Journal:  Mol Biol Rep       Date:  2011-06-19       Impact factor: 2.316

6.  Epigenetic programming underpins B-cell dysfunction in peanut and multi-food allergy.

Authors:  Samira Imran; Melanie R Neeland; Jennifer Koplin; Shyamali Dharmage; Mimi Lk Tang; Susan Sawyer; Thanh Dang; Vicki McWilliam; Rachel Peters; Kirsten P Perrett; Boris Novakovic; Richard Saffery
Journal:  Clin Transl Immunology       Date:  2021-08-24

Review 7.  B-lymphocyte tolerance and effector function in immunity and autoimmunity.

Authors:  Wasif N Khan; Jacqueline A Wright; Eden Kleiman; Justin C Boucher; Iris Castro; Emily S Clark
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

8.  Phagocytosis-dependent activation of a TLR9-BTK-calcineurin-NFAT pathway co-ordinates innate immunity to Aspergillus fumigatus.

Authors:  Susanne Herbst; Anand Shah; Maria Mazon Moya; Vanessa Marzola; Barbara Jensen; Anna Reed; Mark A Birrell; Shinobu Saijo; Serge Mostowy; Sunil Shaunak; Darius Armstrong-James
Journal:  EMBO Mol Med       Date:  2015-03       Impact factor: 12.137

9.  Micro-scale flow cytometry-based and biochemical analysis of lipid signaling in primary B cell subpopulations.

Authors:  Pierre Antony; Kristen Hoek; Bhaskarjyoti Sarmah; Wasif N Khan
Journal:  Biol Proced Online       Date:  2007-12-24       Impact factor: 3.244

Review 10.  Lyn, Lupus, and (B) Lymphocytes, a Lesson on the Critical Balance of Kinase Signaling in Immunity.

Authors:  Erica J Brodie; Simona Infantino; Michael S Y Low; David M Tarlinton
Journal:  Front Immunol       Date:  2018-03-01       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.